Cargando…
Unresponsive Intractable Chronic Headache With Sitagliptin
Sitagliptin is an anti-diabetic medication within the dipeptidyl peptidase 4 (DPP4) inhibitor class used as a single agent or in combination therapy. It is a well-studied and well-tolerated medication with commonly reported adverse events of upper respiratory tract infections, nasopharyngitis, heada...
Autores principales: | Zaghloul, Ahmed, Iorgoveanu, Corina, Polio, Andrew, Desai, Aakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017126/ https://www.ncbi.nlm.nih.gov/pubmed/29946505 http://dx.doi.org/10.7759/cureus.2537 |
Ejemplares similares
-
Kikuchi-Fujimoto Disease in a Young African American Male
por: Zaghloul, Ahmed, et al.
Publicado: (2018) -
Sitagliptin-induced Pancreatitis: Chronic Use Would Not Spare You the Complication
por: Alkayali, Talal, et al.
Publicado: (2020) -
A Rare Case Report of Sitagliptin-Induced Angioedema
por: Sharma, Nava R, et al.
Publicado: (2022) -
Randomized Clinical Trial on Efficacy of Empagliflozin Versus Sitagliptin, In Addition to Metformin in Type 2 Diabetic Patients
por: Mubashir, Muaz, et al.
Publicado: (2022) -
Two PerPLEXing Cases of Hashimoto’s Encephalopathy Unresponsive to Steroid and Intravenous Immunoglobulin Therapy
por: Karan, Abhinav, et al.
Publicado: (2022)